Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6629446

CC(C)C(C(=O)NO)N1CCCC1=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA3 P07451 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6626626 1.00 LMNA (0.41) LMNACA12CA1CA2CA3
SCHEMBL2757978 0.77 LMNA (0.42) LMNACA12CA1CA2CA3
Trifluoroacetic Acid SCHEMBL6630246 0.76 DPP7 (0.34) MMP1MMP2MMP9DPP8PIK3CD
SCHEMBL628286 0.76 LMNA (0.49) LMNACA12CA1CA2CA3
SCHEMBL3725271 0.76 LMNA (0.49) LMNACA12CA1CA2CA3
SCHEMBL6627436 0.75 LMNA (0.47) LMNACA12CA1CA2CA3
SCHEMBL3276152 0.74 LMNA (0.49) LMNACA12CA1CA2CA3
Trifluoroacetic Acid SCHEMBL4471386 0.74 LMNA (0.56) LMNACA12CA1CA2CA3
SCHEMBL8240441 0.73 LMNA (0.49) LMNACA12CA1CA2CA3
Trifluoroacetic Acid SCHEMBL6629131 0.73 LMNA (0.34) LMNACA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1027332-B1 NOVEL LACTAM METALLOPROTEASE INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-05-26 EP disclosed